Benzazole derivatives for the treatment of scleroderma

Details for Australian Patent Application No. 2002352227 (hide)

Owner Laboratoires Serono SA

Inventors Gaillard, Pascale; Gotteland, JeanPierre; Chvatchko, Yolande

Agent Griffith Hack

Pub. Number AU-B-2002352227

PCT Number PCT/EP02/13857

PCT Pub. Number WO2003/047570

Priority 01000727.6 07.12.01 EP

Filing date 6 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 1 November 2007

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4184 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/5377 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/06 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 01000727.6 07.12.01 EP

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002352227

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA Assignments before Grant, Section 113

1 November 2007 Application Accepted

  Published as AU-B-2002352227

28 February 2008 Standard Patent Sealed

23 April 2009 Alteration of Name

  The name of the patentee has been altered to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352228-USE OF 2-HYDROXY OR 2-ACETYLOXY-4-TRIFLUOROMETHY LBENZOIC ACID DERIVATIVES AS AN AGENT FOR THE TREATMENT AND PREVENTION OF MILD COGNITIVE IMPAIRMENT

2002352226-Use of pigment such as E.G. titanium dioxide for obtaining a special optical effect on oral medicament or food